Saccharo Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $11.5M

  • Investors
  • 8

Saccharo General Information

Description

Operator of an immuno-oncology company intended to develop various cancer therapies. The company's therapies utilize a novel polysaccharide-based immune-shielding pathway, enabling healthcare providers to treat patients and cure them.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6401 Chelton Drive
  • Oakland, CA 94611
  • United States
+1 (510)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 6401 Chelton Drive
  • Oakland, CA 94611
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Saccharo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 16-Aug-2022 $11.5M Completed Pre-Clinical Trials
To view Saccharo’s complete valuation and funding history, request access »

Saccharo Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view Saccharo’s complete cap table history, request access »

Saccharo Patents

Saccharo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026015903-A1 De-n-acetylated polysialic acid (dpsa) binding agent conjugates and mel'hod of using same Pending 12-Jul-2024
JP-2026524032-A De-n-acetylated polysialic acid (dpsa) binders, conjugates, and methods of using the same. Pending 12-Jul-2023
AU-2024287644-A1 De-n-acetylated polysialic acid (dpsa) binding agent, conjugates, and method of using same Pending 12-Jul-2023
EP-4743124-A1 De-n-acetylated polysialic acid (dpsa) binding agent, conjugates, and method of using same Pending 12-Jul-2023
WO-2025015281-A1 De-n-acetylated polysialic acid (dpsa) binding agent, conjugates, and method of using same Inactive 12-Jul-2023 A61K47/68031
To view Saccharo’s complete patent history, request access »

Saccharo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Saccharo Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Foreview Ventures Family Office Minority
K2X Venture Capital Minority
Life Science Angels Angel Group Minority
MVP Funds by Moore Venture Partners Venture Capital Minority
Rivermount VC Fund Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Saccharo FAQs

  • When was Saccharo founded?

    Saccharo was founded in 2018.

  • Where is Saccharo headquartered?

    Saccharo is headquartered in Oakland, CA.

  • What is the size of Saccharo?

    Saccharo has 5 total employees.

  • What industry is Saccharo in?

    Saccharo’s primary industry is Drug Discovery.

  • Is Saccharo a private or public company?

    Saccharo is a Private company.

  • What is the current valuation of Saccharo?

    The current valuation of Saccharo is .

  • What is Saccharo’s current revenue?

    The current revenue for Saccharo is .

  • How much funding has Saccharo raised over time?

    Saccharo has raised $11.5M.

  • Who are Saccharo’s investors?

    Foreview Ventures, K2X, Life Science Angels, MVP Funds by Moore Venture Partners, and Rivermount VC Fund are 5 of 8 investors who have invested in Saccharo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process